Tafamidis soft gelatin capsules 20 mg and 61 mg product-specific bioequivalence guidance

HumanScientific guidelines

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

Keywords: Bioequivalence, generics, tafamidis

Open consultation

Tafamidis soft gelatin capsules 20 mg and 61 mg product-specific bioequivalence guidance

Draft: consultation open Consultation dates: to Reference Number: EMA/85747/2026 Summary:

Comments should be provided using this EU Survey form. For any technical issues, please contact the EUSurvey Support.

English (EN) (148.36 KB - PDF)

Esmakordselt avaldatud:
Vaata

Share this page